Race against frostbite: everest doctors test Life-Saving drug on the mountain

NCT ID NCT07450469

Summary

This study aims to see if a drug called iloprost, which can help save frostbitten tissue, can be given safely and effectively at remote high-altitude locations like Everest Basecamp. Researchers will treat up to 10 adult climbers with severe frostbite within 72 hours of injury and monitor them for side effects and long-term outcomes like amputation rates. The goal is to understand the logistical challenges and see if starting treatment on-site, rather than after evacuation, leads to better tissue preservation.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALTITUDE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Eurac Research, Institute of Mountain Emergency Medicine

    Bolzano, BZ, 39100, Italy

Conditions

Explore the condition pages connected to this study.